The FDA has taken umbrage with certain Incyte promotional claims related to its chronic graft-versus-host disease (cGVHD) ...

Retinal diseases are among the fastest growing causes of blindness, having a profound impact on patients’ independence and ...

In a brutal first quarter for Roche, key drugs in the company’s pharmaceutical division fall short of Wall Street ...

With Regeneron poised to announce a drug pricing deal with the White House Thursday, all 17 companies targeted in a round of ...

As pharma giants slash headcounts and routinely strike billion-dol | Amid industry layoffs and M&A headlines, Big Pharma's ...

During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting campaign has ...

While the scale of the currency headwinds in Roche’s first-quarter financial update caught many off guard, the company’s ...

The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift ...

After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the ...

Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his personality ...

Daiichi Sankyo has postponed its annual report by two weeks to allow for additional time to finalize the financial figures. | ...